An Extensive Targeted Proteomic Analysis of Disease-Related Protein Biomarkers in Urine from Healthy Donors

PLoS ONE

Volumn 8, Issue 5, 2013, Pages

  Nolen, Brian M ^a   Orlichenko, Lidiya S ^a   Marrangoni, Adele ^a   Velikokhatnaya, Liudmila ^a   Prosser, Denise ^a   Grizzle, William E ^b   Ho, Kevin ^c   Jenkins, Frank J ^a,c   Bovbjerg, Dana H ^a,c,d   Lokshin, Anna E ^a,c  

^a UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

^b University of Alabama at Birmingham   (United States)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGOUTI RELATED PROTEIN; ALBUMIN; AMYLOID A PROTEIN; APOLIPOPROTEIN A2; APOLIPOPROTEIN B; BETA 2 MICROGLOBULIN; BIOLOGICAL MARKER; CA 125 ANTIGEN; CA 15-3 ANTIGEN; CA 19-9 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; COMPLEMENT COMPONENT C3; COMPLEMENT FACTOR H; CREATININE; FATTY ACID BINDING PROTEIN; FIBRONECTIN; FOLLITROPIN; GLYCOPROTEIN; HUMAN EPIDIDYMIS PROTEIN 4; LUTEINIZING HORMONE; MYELOPEROXIDASE; NERVE CELL ADHESION MOLECULE; OSTEOPONTIN; PREALBUMIN; PROTEIN MDA LDL; PROTEIN SGP130; SQUAMOUS CELL CARCINOMA ANTIGEN; THROMBOSPONDIN; UNCLASSIFIED DRUG; UNINDEXED DRUG; VASCULAR CELL ADHESION MOLECULE 1;

ADULT; AGED; ARTICLE; BETA 2 MICROGLOBULIN URINE LEVEL; CONTROLLED STUDY; CREATININE URINE LEVEL; FEMALE; GLOMERULUS FILTRATION; HORMONE URINE LEVEL; HUMAN; HUMAN EXPERIMENT; IMMUNOASSAY; KIDNEY TUBULE EXCRETION; MALE; NORMAL HUMAN; PROTEIN DETERMINATION; PROTEIN FUNCTION; PROTEIN STRUCTURE; PROTEIN URINE LEVEL; PROTEOMICS; URINALYSIS; WESTERN BLOTTING;

ADULT; AGED; ALBUMINURIA; BETA 2-MICROGLOBULIN; BIOLOGICAL MARKERS; BLOTTING, WESTERN; CA-125 ANTIGEN; CREATININE; DISEASE; FEMALE; HEALTH; HUMANS; MALE; MIDDLE AGED; OSTEOPONTIN; PREALBUMIN; PROTEINS; PROTEOME; PROTEOMICS; REFERENCE STANDARDS; TIME FACTORS;

EID: 84878410246     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0063368     Document Type: Article

References (51)

1. Koomen JM, Li D, Xiao LC, Liu TC, Coombes KR, et al. (2005) Direct tandem mass spectrometry reveals limitations in protein profiling experiments for plasma biomarker discovery. J Proteome Res 4: 972-981.
2. Teisner B, Davey MW, Grudzinskas JG, (1983) Interaction between heparin and plasma proteins analysed by crossed immunoelectrophoresis and affinity chromatography. Clin Chim Acta 127: 413-417.
3. Menon U, Gentry-Maharaj A, Hallett R, Ryan A, Burnell M, et al. (2009) Sensitivity and specificity of multimodal and ultrasound screening for ovarian cancer, and stage distribution of detected cancers: results of the prevalence screen of the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS). Lancet Oncol 10: 327-340.
4. Ye B, Skates S, Mok SC, Horick NK, Rosenberg HF, et al. (2006) Proteomic-based discovery and characterization of glycosylated eosinophil-derived neurotoxin and COOH-terminal osteopontin fragments for ovarian cancer in urine. Clin Cancer Res 12: 432-441.
5. Schaub S, Wilkins J, Weiler T, Sangster K, Rush D, et al. (2004) Urine protein profiling with surface-enhanced laser-desorption/ionization time-of-flight mass spectrometry. Kidney Int 65: 323-332.
6. Gonzalez-Buitrago JM, Ferreira L, Lorenzo I, (2007) Urinary proteomics. Clin Chim Acta 375: 49-56.
7. Pejcic M, Stojnev S, Stefanovic V, (2010) Urinary proteomics - a tool for biomarker discovery. Ren Fail 32: 259-268.
8. Comte B, Franceschi C, Sadoulet MO, Silvy F, Lafitte D, et al. (2006) Detection of bile salt-dependent lipase, a 110 kDa pancreatic protein, in urines of healthy subjects. Kidney Int 69: 1048-1055.
9. Polotsky VY, O'Donnell CP, (2007) Genomics of sleep-disordered breathing. Proc Am Thorac Soc 4: 121-126.
10. Tantipaiboonwong P, Sinchaikul S, Sriyam S, Phutrakul S, Chen ST, (2005) Different techniques for urinary protein analysis of normal and lung cancer patients. Proteomics 5: 1140-1149.
11. Nolen BM, Lokshin AE, (2011) The advancement of biomarker-based diagnostic tools for ovarian, breast, and pancreatic cancer through the use of urine as an analytical biofluid. Int J Biol Markers 26: 141-152.
12. Adachi J, Kumar C, Zhang Y, Olsen JV, Mann M, (2006) The human urinary proteome contains more than 1500 proteins, including a large proportion of membrane proteins. Genome Biol 7: R80.
13. Coon JJ, Zürbig P, Dakna M, Dominiczak AF, Decramer S, et al. (2008) CE-MS Analysis of the Human Urinary Proteome for Biomarker Discovery and Disease Diagnostics. Proteomics - Clinical Applications 2: 964-973.
14. Kentsis A, Monigatti F, Dorff K, Campagne F, Bachur R, et al. (2009) Urine proteomics for profiling of human disease using high accuracy mass spectrometry. Proteomics Clin Appl 3: 1052-1061.
15. N H, AM N, M K, N N, R A, et al. (2012) SEER Cancer Statistics Review, 1975-2009 (Vintage 2009 Populations). National Cancer Institute Bethesda, MD.
16. Yurkovetsky Z, Skates S, Lomakin A, Nolen B, Pulsipher T, et al. (2010) Development of a multimarker assay for early detection of ovarian cancer. J Clin Oncol 28: 2159-2166.
17. Laemmli UK, (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227: 680-685.
18. Towbin H, Staehelin T, Gordon J, (1979) Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci U S A 76: 4350-4354.
19. Burnette WN, (1981) "Western blotting".: electrophoretic transfer of proteins from sodium dodecyl sulfate - polyacrylamide gels to unmodified nitrocellulose and radiographic detection with antibody and radioiodinated protein A. Anal Biochem 112: 195-203.
20. Dyer AR, Greenland P, Elliott P, Daviglus ML, Claeys G, et al. (2004) Evaluation of measures of urinary albumin excretion in epidemiologic studies. Am J Epidemiol 160: 1122-1131.
21. Foundation NK (2002) K/DOQI Clinical Practice Guidelines for Chronic Kidney Disease: evaluation, classification and stratification. American Journal of Kidney Disease 39: S1-S266.
22. Tojo A, Endou H, (1992) Intrarenal handling of proteins in rats using fractional micropuncture technique. Am J Physiol 263: F601-606.
23. Takashi M, Zhu Y, Miyake K, Kato K, (1996) Urinary 28-kD calbindin-D as a new marker for damage to distal renal tubules caused by cisplatin-based chemotherapy. Urol Int 56: 174-179.
24. Dieterle F, Perentes E, Cordier A, Roth DR, Verdes P, et al. (2010) Urinary clusterin, cystatin C, beta2-microglobulin and total protein as markers to detect drug-induced kidney injury. Nat Biotechnol 28: 463-469.
25. Vinken P, Starckx S, Barale-Thomas E, Looszova A, Sonee M, et al. (2012) Tissue Kim-1 and Urinary Clusterin as Early Indicators of Cisplatin-Induced Acute Kidney Injury in Rats. Toxicol Pathol.
26. Hazzaa SM, Elashry OM, Afifi IK, (2010) Clusterin as a diagnostic and prognostic marker for transitional cell carcinoma of the bladder. Pathol Oncol Res 16: 101-109.
27. Delles C, Schiffer E, von Zur Muhlen C, Peter K, Rossing P, et al. (2010) Urinary proteomic diagnosis of coronary artery disease: identification and clinical validation in 623 individuals. J Hypertens 28: 2316-2322.
28. Linden M, Lind SB, Mayrhofer C, Segersten U, Wester K, et al. (2012) Proteomic analysis of urinary biomarker candidates for nonmuscle invasive bladder cancer. Proteomics 12: 135-144.
29. Navarro-Munoz M, Ibernon M, Bonet J, Perez V, Pastor MC, et al. (2012) Uromodulin and alpha(1)-Antitrypsin Urinary Peptide Analysis to Differentiate Glomerular Kidney Diseases. Kidney Blood Press Res 35: 314-325.
30. Steinhoff J, Einecke G, Niederstadt C, Fricke L, Rob PM, et al. (1997) Myeloperoxidase in urine: a new marker for distinction between rejection and urinary tract infection after renal transplantation. Transplant Proc 29: 3098.
31. Shio K, Kobayashi H, Asano T, Saito R, Iwadate H, et al. (2010) Thrombin-cleaved osteopontin is increased in urine of patients with rheumatoid arthritis. J Rheumatol 37: 704-710.
32. Obeidat M, Ballermann BJ, (2012) Glomerular endothelium: a porous sieve and formidable barrier. Exp Cell Res 318: 964-972.
33. Kreunin P, Zhao J, Rosser C, Urquidi V, Lubman DM, et al. (2007) Bladder cancer associated glycoprotein signatures revealed by urinary proteomic profiling. J Proteome Res 6: 2631-2639.
34. Yang N, Feng S, Shedden K, Xie X, Liu Y, et al. (2011) Urinary glycoprotein biomarker discovery for bladder cancer detection using LC/MS-MS and label-free quantification. Clin Cancer Res 17: 3349-3359.
35. Pisitkun T, Shen RF, Knepper MA, (2004) Identification and proteomic profiling of exosomes in human urine. Proc Natl Acad Sci U S A 101: 13368-13373.
36. Hellstrom I, Heagerty PJ, Swisher EM, Liu P, Jaffar J, et al. (2010) Detection of the HE4 protein in urine as a biomarker for ovarian neoplasms. Cancer Lett 296: 43-48.
37. Bingle L, Singleton V, Bingle CD, (2002) The putative ovarian tumour marker gene HE4 (WFDC2), is expressed in normal tissues and undergoes complex alternative splicing to yield multiple protein isoforms. Oncogene 21: 2768-2773.
38. Shiraga H, Min W, VanDusen WJ, Clayman MD, Miner D, et al. (1992) Inhibition of calcium oxalate crystal growth in vitro by uropontin: another member of the aspartic acid-rich protein superfamily. Proc Natl Acad Sci U S A 89: 426-430.
39. Bautista DS, Denstedt J, Chambers AF, Harris JF, (1996) Low-molecular-weight variants of osteopontin generated by serine proteinases in urine of patients with kidney stones. J Cell Biochem 61: 402-409.
40. Tay SK, Chua EK, (1994) Correlation of serum, urinary and salivary CA 125 levels in patients with adnexal masses. Ann Acad Med Singapore 23: 311-314.
41. Ammon A, Weber MH, Wallner I, Marschner N, Droese M, et al. (1995) Immunocytochemical determination of the tumor-associated glycoproteins MCA, CA 125 and BW 495/36-P in urine of patients with epithelial tumors of the kidney and urinary bladder. Int J Biol Markers 10: 17-23.
42. Basaran A, Zafer Tuncer S, (2007) Ascites is the primary cause of cancer antigen-125 (CA-125) elevation in systemic lupus erythematosus (SLE) patients with nephrotic syndrome. Med Hypotheses 68: 197-201.
43. Gollapalli K, Ray S, Srivastava R, Renu D, Singh P, et al. (2012) Investigation of serum proteome alterations in human glioblastoma multiforme. Proteomics.
44. Bigbee WL, Gopalakrishnan V, Weissfeld JL, Wilson DO, Dacic S, et al. (2012) A multiplexed serum biomarker immunoassay panel discriminates clinical lung cancer patients from high-risk individuals found to be cancer-free by CT screening. J Thorac Oncol 7: 698-708.
45. Riaz S, Alam SS, Srai SK, Skinner V, Riaz A, et al. (2010) Proteomic identification of human urinary biomarkers in diabetes mellitus type 2. Diabetes Technol Ther 12: 979-988.
46. Huang JT, Leweke FM, Oxley D, Wang L, Harris N, et al. (2006) Disease biomarkers in cerebrospinal fluid of patients with first-onset psychosis. PLoS Med 3: e428.
47. Liu L, Sun S, Liu J, Wu S, Dai S, et al. (2009) [A new serum biomarker for lung cancer - transthyretin.]. Zhongguo Fei Ai Za Zhi 12: 300-305.
48. Hjalmarsson C, Johansson BR, Haraldsson B, (2004) Electron microscopic evaluation of the endothelial surface layer of glomerular capillaries. Microvasc Res 67: 9-17.
49. Rostgaard J, Qvortrup K, (2002) Sieve plugs in fenestrae of glomerular capillaries - site of the filtration barrier? Cells Tissues Organs 170: 132-138.
50. Friden V, Oveland E, Tenstad O, Ebefors K, Nystrom J, et al. (2011) The glomerular endothelial cell coat is essential for glomerular filtration. Kidney Int 79: 1322-1330.
51. Salmon AH, Satchell SC, (2012) Endothelial glycocalyx dysfunction in disease: albuminuria and increased microvascular permeability. J Pathol 226: 562-574.